Vectura’s Podcast
Evolution of the Nebuliser - Daniel Lock

Evolution of the Nebuliser - Daniel Lock

October 22, 2021

Daniel Lock, Specialist - Pharmaceutical Development shares his insights on the evolution of nebulisers, and how advancements in technology can improve patient care and inhaled product development. In this episode, Dan discusses how smart nebulisers can improve lung deposition for inhaled therapies, provide valuable patient data in clinical trials, and expand the profile of patients who may benefit from nebulised treatment.

Vectura Group’s 2020 preliminary results

Vectura Group’s 2020 preliminary results

March 18, 2021

Hear from Vectura’s CEO Will Downie as shares his thoughts on our performance in 2020 and the progress we’ve made transforming to become a market leading inhalation CDMO.

The challenges of developing inhaled generics medicines - Martin Oliver

The challenges of developing inhaled generics medicines - Martin Oliver

December 17, 2020

What are the unique challenges involved in developing inhaled generic medicines? Following the US FDA’s approval of VR315 (US), hear from Martin Oliver, our SVP Delivery Management – DPI and pMDI Platforms, as he explains in this podcast.

Our science and CDMO transformation - Sharon Johnson

Our science and CDMO transformation - Sharon Johnson

December 4, 2020

In our latest episode, hear Sharon Johnson, our EVP Delivery Management, talk about the importance of science at Vectura, our inhalation CDMO transformation, managing the challenges of COVID-19 and leadership.

“There’s a patient at the end of every piece of work we do…” - Will Downie

“There’s a patient at the end of every piece of work we do…” - Will Downie

October 7, 2020

In the latest podcast in our series, Will Downie Vectura’s CEO talks about coping with the COVID crisis, our CDMO transformation and delivering for customers and patients.

New trends in device development - Andreas Meliniotis

New trends in device development - Andreas Meliniotis

June 17, 2020

Andreas Meliniotis, Director of Device Development, shares his insights on new trends in device development and how simplicity, usability and connectivity ultimately helps patients. Andreas will also help navigate the complex area of DPI combination product development in a free webcast on 24th June. Register here: https://bit.ly/30qtaz4

Breathing New Life into Existing Drugs – Geraldine Venthoye

Breathing New Life into Existing Drugs – Geraldine Venthoye

May 18, 2020

How do you identify the best opportunities to repurpose or reposition existing drugs for inhaled administration? Geraldine Venthoye, EVP Product Development, shares her insights and talks about Vectura’s capabilities in the inhalation space. You can also read more in the latest edition of Medicine Maker here.

Getting ready for digital RDD 2020 – Sandy Munro

Getting ready for digital RDD 2020 – Sandy Munro

April 24, 2020

Sandy Munro, VP of Pharmaceutical Development, talks about Vectura’s involvement in the all-digital Respiratory Drug Delivery Congress 2020, the science we’ll be presenting, and how we’re helping customers develop inhaled medicines.